$200K — $250K *
Evelo Biosciences, Inc. (Nasdaq: EVLO) a biotechnology company developing a new modality of orally delivered, systemically acting biologics that could disrupt the industry is looking for a highly motivated individual who is energized by the prospect of working in a clinical stage company, has a strong desire to learn, and wishes to be an integral member of an interdisciplinary team.
We are seeking a talented and dedicated individual who is interested in joining a high performing, intellectually stimulating team of drug discoverers and developers. This role will provide an exciting opportunity to contribute to the new and rapidly developing field of research and development, working as part of a dynamic startup with tremendous growth potential.
Reporting to the Head of Formulation, this position is accountable for early to late-stage development of robust solid oral formulations and process. You will be responsible for tech transfer activities to the CMOs for clinical manufacturing. With your proven track record of late-stage development and commercialization in small molecule area, you will be leading scaleup/process optimization activities towards pilot scale, pivotal, and commercial batch manufacturing. You will also be responsible for authoring technical and manufacturing reports and regulatory submissions such as IND, IMPD, BLA.
Desired Skills & Qualifications:
About Evelo Biosciences
Evelo Biosciences is a clinical stage biotechnology company developing oral biologics that act on SINTAX™, the small intestinal axis, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic and neurological systems. The company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer.
Valid through: 11/19/2021
$200K — $250K *
8 days ago
$250K — $250K+*
3 days ago
$120K — $170K + $25K bonus *
5 days ago